Contemporary Pediatrics connects pediatricians with peer-reviewed articles, guideline updates, and practice strategies for real-world clinical application.

Joshua Fitch is the senior editor for Contemporary Pediatrics. He joined the brand in March of 2023 as an editor before being promoted to senior editor in January 2024. Fitch graduated from Youngstown ...

A session of the American College of Obstetricians and Gynecologists 2021 annual meeting pointed to the dramatic increase in sexually transmitted infections (STIs) in the United States and presented ...

On June 12, a new phase 3 clinical study of the Vimkunya single-dose, virus-like particle (VLP) chikungunya vaccine was initiated by Bavarian Nordic A/S among children aged 2 to 11 years, according to ...

A recent study found screen time and socioemotional problems in children are linked in both directions, with gaming tied to greater risk than other activities. A large-scale analysis of 117 studies ...

Primary care providers may be the first line of defense for children with pediatric acute-onset neuropsychiatric syndrome (PANS), but diagnosing and managing the condition can present significant ...

The label expansion allows for immediate treatment at diagnosis in patients aged ≥3 years without cirrhosis or with compensated cirrhosis. In a phase 3 trial, 96.2% of patients with acute HCV achieved ...

Aaron Milstone, MD, MHS, pediatric infectious disease specialist at Johns Hopkins Children’s Center and professor of pediatrics at Johns Hopkins University School of Medicine, emphasized the ...

A study recently published in JAMA Pediatrics found that US states with permissive firearm laws saw significantly more pediatric firearm deaths following the 2010 Supreme Court ruling in McDonald v ...

Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study of 1.3M women finds. A nationwide study from Karolinska Institutet has found a ...

John Browning, MD, highlights the importance of fragrance-free, steroid-free creams in managing atopic dermatitis safely and effectively in children. For pediatricians treating children with atopic ...

The June 9, 2025, FDA approval of clesrovimab (Enflonsia; Merck) marked another advancement for the prevention of respiratory syncytial virus (RSV) disease in infants, especially during their first ...